<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Garrido J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10-20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung Cancer (NSCLC) there are clear differences in both the clinical presentation and the tumor genomic profiles between smokers and never-smokers. For example, the Lung Adenocarcinoma (LUAD) histological subtype in never-smokers is predominately found in young women of European, North American, and Asian descent. While the clinical presentation and tumor genomic profiles of smokers have been widely examined, never-smokers are usually underrepresented, especially those of a Latin American (LA) background. In this work, we characterize, for the first time, the difference in the genomic profiles betwee</pubmed_abstract><journal>BMC cancer</journal><pagination>951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11297669</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers.</pubmed_title><pmcid>PMC11297669</pmcid><pubmed_authors>Aren O</pubmed_authors><pubmed_authors>de Amorim MG</pubmed_authors><pubmed_authors>Aguila JF</pubmed_authors><pubmed_authors>Owen G</pubmed_authors><pubmed_authors>Freitas HC</pubmed_authors><pubmed_authors>Blanco A</pubmed_authors><pubmed_authors>Freire M</pubmed_authors><pubmed_authors>Armisen R</pubmed_authors><pubmed_authors>Perez P</pubmed_authors><pubmed_authors>Dias-Neto E</pubmed_authors><pubmed_authors>Ibanez C</pubmed_authors><pubmed_authors>Spencer ML</pubmed_authors><pubmed_authors>Bartelli TF</pubmed_authors><pubmed_authors>Bernal Y</pubmed_authors><pubmed_authors>Corvalan A</pubmed_authors><pubmed_authors>Lizana R</pubmed_authors><pubmed_authors>Olea MA</pubmed_authors><pubmed_authors>Fernandez C</pubmed_authors><pubmed_authors>Assar R</pubmed_authors><pubmed_authors>Ampuero D</pubmed_authors><pubmed_authors>Marcelain K</pubmed_authors><pubmed_authors>Chernilo S</pubmed_authors><pubmed_authors>Gonzalez E</pubmed_authors><pubmed_authors>Sepulveda-Hermosilla G</pubmed_authors><pubmed_authors>Rasse G</pubmed_authors><pubmed_authors>Garrido M</pubmed_authors><pubmed_authors>Sanchez C</pubmed_authors><pubmed_authors>Garrido J</pubmed_authors><pubmed_authors>Ramos L</pubmed_authors><pubmed_authors>Nunes DN</pubmed_authors><pubmed_authors>Rivas S</pubmed_authors><pubmed_authors>Caceres-Molina J</pubmed_authors><pubmed_authors>Orostica K</pubmed_authors><pubmed_authors>Dossetto GB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers.</name><description>&lt;h4>Background&lt;/h4>Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10-20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung Cancer (NSCLC) there are clear differences in both the clinical presentation and the tumor genomic profiles between smokers and never-smokers. For example, the Lung Adenocarcinoma (LUAD) histological subtype in never-smokers is predominately found in young women of European, North American, and Asian descent. While the clinical presentation and tumor genomic profiles of smokers have been widely examined, never-smokers are usually underrepresented, especially those of a Latin American (LA) background. In this work, we characterize, for the first time, the difference in the genomic profiles betwee</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-05-04T06:36:20.264Z</modification><creation>2026-04-22T03:09:45.16Z</creation></dates><accession>S-EPMC11297669</accession><cross_references><pubmed>39097719</pubmed><doi>10.1186/s12885-024-12737-1</doi></cross_references></HashMap>